Newly developed electronic nose (eNose) can tell doctors which lung cancer patients are more likely respond to immunotherapy, reports a new study. The findings of the study are published in the leading cancer journal iAnnals of Oncology/i.
An electronic nose that detects chemicals in the breath of lung cancer patients can identify with 85% accuracy those who will or will not respond to immunotherapy, according to new research.
The results of the first study to investigate this show that ...
Newly developed electronic nose (eNose) can tell doctors which lung cancer patients are more likely respond to immunotherapy, reports a new study. The findings of the study are published in the leading cancer journal iAnnals of Oncology/i.
An electronic nose that detects chemicals in the breath of lung cancer patients can identify with 85% accuracy those who will or will not respond to immunotherapy, according to new research.
The results of the first study to investigate this show that ...